MIZUHO MEDY CO.,LTD. Logo

MIZUHO MEDY CO.,LTD.

Develops rapid diagnostic tests & gene analyzers for clinical, research & agricultural markets.

4595 | T

Overview

Corporate Details

ISIN(s):
JP3885900005
LEI:
Country:
Japan
Address:
鳥栖市藤木町5番地の4
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Mizuho Medy Co., Ltd. is an in vitro diagnostics (IVD) company that specializes in the research, development, manufacturing, and sale of diagnostic products. The company's portfolio focuses on rapid immunoassay and nucleic acid amplification technologies, with a significant emphasis on point-of-care testing (POCT) reagents. Its product lines include the 'Quick Chaser' series for detecting infectious diseases like influenza, RSV, and SARS-CoV-2, and the 'Quick Checker' series for hormonal tests such as pregnancy and ovulation. In addition to diagnostic kits, Mizuho Medy develops instruments like fully automated gene analyzers. The company serves the clinical, research, and agricultural markets and operates under the ISO 13485 quality management standard for medical devices.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-08 06:06
Interim Report
確認書
Japanese 8.7 KB
2025-08-08 06:04
Interim Report
半期報告書-第49期(2025/01/01-2025/12/31)
Japanese 204.8 KB
2025-04-02 06:17
Post-Annual General Meeting Information
臨時報告書
Japanese 25.9 KB
2025-03-31 03:44
Governance Information
内部統制報告書-第48期(2024/01/01-2024/12/31)
Japanese 22.5 KB
2025-03-31 03:41
Registration Form
確認書
Japanese 8.7 KB
2025-03-31 03:37
Annual Report
有価証券報告書-第48期(2024/01/01-2024/12/31)
Japanese 931.6 KB
2024-08-09 06:11
Regulatory News Service
確認書
Japanese 8.7 KB
2024-08-09 06:09
Interim Report
半期報告書-第48期(2024/01/01-2024/12/31)
Japanese 209.8 KB
2024-05-10 06:07
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-05-10 06:06
Quarterly Report
四半期報告書-第48期第1四半期(2024/01/01-2024/03/31)
Japanese 169.5 KB
2024-04-01 09:48
Post-Annual General Meeting Information
臨時報告書
Japanese 21.6 KB
2024-03-29 02:02
Governance Information
内部統制報告書-第47期(2023/01/01-2023/12/31)
Japanese 22.5 KB
2024-03-29 01:59
Registration Form
確認書
Japanese 8.7 KB
2024-03-29 01:56
Annual Report
有価証券報告書-第47期(2023/01/01-2023/12/31)
Japanese 967.0 KB
2023-11-10 05:09
Report Publication Announcement
確認書
Japanese 8.7 KB

Automate Your Workflow. Get a real-time feed of all MIZUHO MEDY CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MIZUHO MEDY CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MIZUHO MEDY CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea
007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea
293780
Aptahem AB Logo
Develops RNA aptamers to treat acute, life-threatening conditions like sepsis.
Sweden
APTA
Aptamer Sciences Inc Logo
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
South Korea
291650
Aptevo Therapeutics Inc. Logo
Developing multi-specific antibody immunotherapies for hematologic and solid tumor cancers.
United States of America
APVO
Aptorum Group Ltd Logo
Biopharma developing novel therapeutics for oncology, infectious and metabolic diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Develops oral film drugs for CNS disorders and severe allergies.
United States of America
AQST
Arbutus Biopharma Corp Logo
A clinical-stage virology company developing a functional cure for chronic hepatitis B (HBV).
United States of America
ABUS
Arcellx, Inc. Logo
Engineering controllable cell therapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway
ABS

Talk to a Data Expert

Have a question? We'll get back to you promptly.